Interleukin-6 and Type 1 Interferons Inhibit Varicella Zoster Virus Replication in Human Neurons

Overview

Journal Virology

Specialty Microbiology

Date 2018 Jul 7

PMID 29979960

Citations 15

Authors

Christina N Como

Catherine M Pearce

Randall J Cohrs

Nicholas L Baird

Affiliations

Soon will be listed here.

Abstract

Varicella zoster virus (VZV) is a neurotropic alphaherpesvirus that, following primary infection (varicella), establishes latency in sensory, autonomic, sympathetic and parasympathetic neurons, where it remains until reactivation (zoster). VZV-specific cell-mediated immune responses maintain VZV latency; thus, immunosuppressed and elderly persons are at risk of reactivation and associated neurological diseases. However, the cytokines produced by the immune system that control VZV in neurons are largely unknown. Therefore, to better understand how the immune system may restrict VZV in neurons, we studied interleukin-6, tumor necrosis factor-alpha and type 1 interferons for their ability to inhibit VZV replication in human neurons in vitro. Our studies revealed that VZV transcription and viral spread were significantly reduced by interleukin-6 and type 1 interferons, and to a lesser extent by tumor necrosis factor-alpha. These findings will help in understanding how the innate immune system limits virus replication in neurons in vivo.

Citing Articles

Identifying and Evaluating Biological Markers of Postherpetic Neuralgia: A Comprehensive Review.

Li Y, Jin J, Kang X, Feng Z Pain Ther. 2024; 13(5):1095-1117.

PMID: 39126594 PMC: 11393369. DOI: 10.1007/s40122-024-00640-3.

The potential of IFN-λ, IL-32γ, IL-6, and IL-22 as safeguards against human viruses: a systematic review and a meta-analysis.

Sattar A, Qaiser A, Kausar H, Aqil S, Mudassar R, Manzoor S Front Immunol. 2024; 15:1303115.

PMID: 38420119 PMC: 10899505. DOI: 10.3389/fimmu.2024.1303115.

Analysis of the Risk Factors for Mechanical Allodynia in Herpetic Neuralgia: A Retrospective Cross-Sectional Study.

Xu G, Gong W, Dong S, Hu G, Tang W, Yu H J Pain Res. 2023; 16:3309-3318.

PMID: 37808462 PMC: 10557995. DOI: 10.2147/JPR.S417454.

Unusual herpetic reactivation in a young female following botox injection: a case report study.

Amini-Salehi E, Eslami N, Tamimi A, Sedighi N, Moghdam S, Yaghubi-Kalurazi T BMC Infect Dis. 2023; 23(1):647.

PMID: 37784014 PMC: 10546652. DOI: 10.1186/s12879-023-08514-3.

Varicella-Zoster Virus ORF39 Transmembrane Protein Suppresses Interferon-Beta Promoter Activation by Interacting with STING.

Lee G, Gong S, Seo S, Ko H, Chung W, Lee J J Microbiol. 2023; 61(2):259-270.

PMID: 36808561 DOI: 10.1007/s12275-023-00019-7.

References

Mahalingam R, Wellish M, Wolf W, Dueland A, Cohrs R, Vafai A . Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med. 1990; 323(10):627-31. DOI: 10.1056/NEJM199009063231002. View

Weinberg A, Levin M . VZV T cell-mediated immunity. Curr Top Microbiol Immunol. 2010; 342:341-57. DOI: 10.1007/82_2010_31. View

Gowrishankar K, Steain M, Cunningham A, Rodriguez M, Blumbergs P, Slobedman B . Characterization of the host immune response in human Ganglia after herpes zoster. J Virol. 2010; 84(17):8861-70. PMC: 2919016. DOI: 10.1128/JVI.01020-10. View

Martinez-Taboada V, Alvarez L, RuizSoto M, Marin-Vidalled M, Lopez-Hoyos M . Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine. 2008; 44(2):207-20. DOI: 10.1016/j.cyto.2008.09.004. View

Hohmann H, Remy R, Brockhaus M, van Loon A . Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem. 1989; 264(25):14927-34. View

Merlin G, FALCOFF E, Aguet M . 125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data. J Gen Virol. 1985; 66 ( Pt 5):1149-52. DOI: 10.1099/0022-1317-66-5-1149. View

Jones D, Alvarez E, Selva S, Gilden D, Nagel M . Proinflammatory cytokines and matrix metalloproteinases in CSF of patients with VZV vasculopathy. Neurol Neuroimmunol Neuroinflamm. 2016; 3(4):e246. PMC: 4907802. DOI: 10.1212/NXI.0000000000000246. View

Gilden D, Rozenman Y, Murray R, Devlin M, Vafai A . Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann Neurol. 1987; 22(3):377-80. DOI: 10.1002/ana.410220315. View

Saylor D, Thakur K, Venkatesan A . Acute encephalitis in the immunocompromised individual. Curr Opin Infect Dis. 2015; 28(4):330-6. DOI: 10.1097/QCO.0000000000000175. View

10.

Gilden D, White T, Khmeleva N, Boyer P, Nagel M . VZV in biopsy-positive and -negative giant cell arteritis: Analysis of 100+ temporal arteries. Neurol Neuroimmunol Neuroinflamm. 2016; 3(2):e216. PMC: 4794807. DOI: 10.1212/NXI.0000000000000216. View

11.

Rosato P, Leib D . Neuronal Interferon Signaling Is Required for Protection against Herpes Simplex Virus Replication and Pathogenesis. PLoS Pathog. 2015; 11(7):e1005028. PMC: 4495997. DOI: 10.1371/journal.ppat.1005028. View

12.

Grell M, Becke F, Wajant H, Mannel D, Scheurich P . Tumor necrosis factor (TNF) receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. Eur J Immunol. 1998; 28(1):257-63. DOI: 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G. View

13.

Furie R, Khamashta M, Merrill J, Werth V, Kalunian K, Brohawn P . Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017; 69(2):376-386. PMC: 5299497. DOI: 10.1002/art.39962. View

14.

Leong K, Karsan A . Signaling pathways mediated by tumor necrosis factor alpha. Histol Histopathol. 2000; 15(4):1303-25. DOI: 10.14670/HH-15.1303. View

15.

Yang L, Lindholm K, Konishi Y, Li R, Shen Y . Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J Neurosci. 2002; 22(8):3025-32. PMC: 6757531. DOI: 20026317. View

16.

Cacciapaglia F, Zuccaro C, Iannone F . Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era. Clin Exp Rheumatol. 2015; 33(6):917-23. View

17.

Gershon A, Chen J, Davis L, Krinsky C, Cowles R, Reichard R . Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans Am Clin Climatol Assoc. 2013; 123:17-33. PMC: 3540599. View

18.

Minassian C, Thomas S, Smeeth L, Douglas I, Brauer R, Langan S . Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States. PLoS Med. 2015; 12(12):e1001919. PMC: 4682931. DOI: 10.1371/journal.pmed.1001919. View

19.

Garcia-Doval I, Perez-Zafrilla B, Descalzo M, Rosello R, Hernandez M, Gomez-Reino J . Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann Rheum Dis. 2010; 69(10):1751-5. DOI: 10.1136/ard.2009.125658. View

20.

Khamashta M, Merrill J, Werth V, Furie R, Kalunian K, Illei G . Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2016; 75(11):1909-1916. PMC: 5099191. DOI: 10.1136/annrheumdis-2015-208562. View